Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9278971
APP PUB NO 20140288082A1
SERIAL NO

14296016

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to compounds of the general formula:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICALS U S A INC500 KENDALL STREET CAMBRIDGE MA 02139

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dalgarno, David C Brookline, US 55 602
Huang, Wei-Sheng Acton, US 58 567
Metcalf,, III Chester A Needham, US 45 410
Qi, Jiwei West Roxbury, US 29 416
Romero, Jan Antoinette C Somerville, US 22 330
Sawyer, Tomi K Southborough, US 81 1787
Shakespeare, William C Southborough, US 74 1018
Sundaramoorthi, Rajeswari Watertown, US 30 396
Thomas, R Mathew Sharon, US 22 396
Wang, Yihan Newton, US 122 1020
Zhu, Xiaotian Newton, US 73 1222
Zou, Dong Concord, US 30 436

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00